Christopher W. Fulton

Array ( [id] => 3623061 [patent_doc_number] => 05688913 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'CS-1 peptidomimetics, compositions and methods of using the same' [patent_app_type] => 1 [patent_app_number] => 8/435286 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 18808 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 287 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688913.pdf [firstpage_image] =>[orig_patent_app_number] => 435286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3787209 [patent_doc_number] => 05736520 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Peptidase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/434959 [patent_app_country] => US [patent_app_date] => 1995-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8569 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736520.pdf [firstpage_image] =>[orig_patent_app_number] => 434959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3737875 [patent_doc_number] => 05698673 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Peptides having anti-melittin activity' [patent_app_type] => 1 [patent_app_number] => 8/434761 [patent_app_country] => US [patent_app_date] => 1995-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18089 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698673.pdf [firstpage_image] =>[orig_patent_app_number] => 434761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3627342 [patent_doc_number] => 05621073 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Chromatographic process for purification of insulin' [patent_app_type] => 1 [patent_app_number] => 8/430273 [patent_app_country] => US [patent_app_date] => 1995-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4455 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/621/05621073.pdf [firstpage_image] =>[orig_patent_app_number] => 430273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661480 [patent_doc_number] => 05624894 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Brain-enhanced delivery of neuroactive peptides by sequential metabolism' [patent_app_type] => 1 [patent_app_number] => 8/428488 [patent_app_country] => US [patent_app_date] => 1995-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 42911 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 447 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624894.pdf [firstpage_image] =>[orig_patent_app_number] => 428488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3884038 [patent_doc_number] => 05798442 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-25 [patent_title] => 'Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases' [patent_app_type] => 1 [patent_app_number] => 8/426547 [patent_app_country] => US [patent_app_date] => 1995-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 19851 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/798/05798442.pdf [firstpage_image] =>[orig_patent_app_number] => 426547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 663545 [patent_doc_number] => 07101937 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-05 [patent_title] => 'Dendritic based macromolecules' [patent_app_type] => utility [patent_app_number] => 08/422627 [patent_app_country] => US [patent_app_date] => 1995-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6547 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101937.pdf [firstpage_image] =>[orig_patent_app_number] => 08422627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808938 [patent_doc_number] => 05811398 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Platelet aggregation inhibitors containing C-terminal aminergic side chain amino acid residues' [patent_app_type] => 1 [patent_app_number] => 8/419793 [patent_app_country] => US [patent_app_date] => 1995-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4849 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811398.pdf [firstpage_image] =>[orig_patent_app_number] => 419793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3633741 [patent_doc_number] => 05610142 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-11 [patent_title] => 'Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids' [patent_app_type] => 1 [patent_app_number] => 8/416524 [patent_app_country] => US [patent_app_date] => 1995-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11400 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 276 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/610/05610142.pdf [firstpage_image] =>[orig_patent_app_number] => 416524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045844 [patent_doc_number] => 05874569 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Method of preparing tresyl-activated dextran, article having tresyl-activated dextran fixed covalently to its surface, and immobilization of chemical compounds thereto' [patent_app_type] => 1 [patent_app_number] => 8/379675 [patent_app_country] => US [patent_app_date] => 1995-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 9239 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874569.pdf [firstpage_image] =>[orig_patent_app_number] => 379675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689890 [patent_doc_number] => 05696229 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Polypeptide with laminin cell adhesion and morphogenesis activity' [patent_app_type] => 1 [patent_app_number] => 8/405200 [patent_app_country] => US [patent_app_date] => 1995-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 27 [patent_no_of_words] => 11028 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696229.pdf [firstpage_image] =>[orig_patent_app_number] => 405200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771865 [patent_doc_number] => 05734018 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Peptide mixtures' [patent_app_type] => 1 [patent_app_number] => 8/404868 [patent_app_country] => US [patent_app_date] => 1995-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 11253 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/734/05734018.pdf [firstpage_image] =>[orig_patent_app_number] => 404868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4051452 [patent_doc_number] => 05969100 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Peptide, peptide analog and amino acid analog protease inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/403420 [patent_app_country] => US [patent_app_date] => 1995-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34197 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/969/05969100.pdf [firstpage_image] =>[orig_patent_app_number] => 403420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3777158 [patent_doc_number] => 05817756 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Pseudo- and non-peptide bradykinin receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 8/401595 [patent_app_country] => US [patent_app_date] => 1995-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15355 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 302 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817756.pdf [firstpage_image] =>[orig_patent_app_number] => 401595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3888847 [patent_doc_number] => 05777104 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Cephem derivatives as anti-metastatic agents' [patent_app_type] => 1 [patent_app_number] => 8/392744 [patent_app_country] => US [patent_app_date] => 1995-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4989 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1365 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/777/05777104.pdf [firstpage_image] =>[orig_patent_app_number] => 392744 [rel_patent_id] =>[rel_patent_doc_number] =>)